Professor Sir Peng Tee Khaw

Director
NIHR Biomedical Research ...

Professor of Glaucoma and Ocular Healing and Consultant Ophthalmic Surgeon.
Director of the NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology; Eyes and Vision Programme, UCL Partners Academic Health Science Centre; and Research and Development, Moorfields Eye Hospital.

Sir Peng’s research interests are in developing new therapies, particularly for preventing scarring and regeneration, with a special interest in paediatric and young adult glaucoma. He has developed surgical techniques including the Moorfields Safer Surgery System, which have markedly improved the safety and outcomes of antimetabolite-assisted trabeculectomy in many parts of the world, especially reducing bleb related endophthalmitis and blebitis. He has developed anti-scarring regimens, which have led to international clinical trials. Currently, he is developing new anti-scarring drugs and delivery system, as well as devices, and has proposed the 10-10-10 challenge for glaucoma around the world: an intraocular pressure of 10 mmHg for 10 years done in 10 minutes. He has also published the ‘energy’ theory of glaucomatous axonopathy, helping move towards stem cell regenerative therapies for the optic nerve.
His publications include over 450 papers, chapters and books, and has helped raise over £120 million for clinical and research facilities, including the world’s largest children’s eye hospital. He was the first British President of ARVO and with his group has won some 25 awards, which include the first international ARVO/Pfizer Ophthalmic Translational Research Award; Alcon Research Institute Award; Sir Stewart Duke Elder Lecture & Medal Royal College of Ophthalmologists; 12th Lang Lecture Medal Royal Society of Medicine; the 23rd Dame Ida Mann Lecture Oxford University; and Hunterian Professorship at the Royal College of Surgeons of England.

Sir Peng was knighted in 2013 for services to ophthalmology by Her Majesty Queen Elizabeth II.